Opus Genetics Inc (IRD)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 12-2024 | 09-2024 | 06-2024 | 03-2024 | 12-2023 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 30,321 | 36,632 | 41,409 | 47,161 | 50,501 |
| Marketable Securities | 2 | 3 | 5 | 5 | 15 |
| Receivables | 3,563 | 1,857 | 1,358 | 1,924 | 926 |
| Other current assets | 2,209 | 1,468 | 948 | 1,194 | 1,407 |
| TOTAL | $36,610 | $40,389 | $44,834 | $51,844 | $53,948 |
| Non-Current Assets | |||||
| PPE Net | 252 | N/A | N/A | N/A | N/A |
| TOTAL | $252 | $N/A | $N/A | $N/A | $N/A |
| Total Assets | $36,862 | $40,389 | $44,834 | $51,844 | $53,948 |
| Liabilities | |||||
| Current Liabilities | |||||
| Accounts payable and accrued liabilities | 3,148 | 844 | 634 | 2,064 | 2,153 |
| Accrued Expenses | 8,147 | 5,171 | 3,490 | 3,649 | 1,815 |
| Other current liabilities | N/A | 74 | 74 | 74 | 74 |
| TOTAL | $11,295 | $6,089 | $4,198 | $5,787 | $4,042 |
| Non-Current Liabilities | |||||
| Other Non-Current Liabilities | 18,843 | 0 | 0 | 0 | 0 |
| TOTAL | $18,843 | $N/A | $N/A | $N/A | $N/A |
| Total Liabilities | $30,138 | $6,089 | $4,198 | $5,787 | $4,042 |
| Shareholders' Equity | |||||
| Shares Outstanding, K | 45,484 | 31,568 | 26,198 | 25,924 | 24,813 |
| Common Shares | 3 | 3 | 3 | 3 | 2 |
| Retained earnings | -138,998 | -103,863 | -96,337 | -88,572 | -81,466 |
| TOTAL | $6,724 | $34,300 | $40,636 | $46,057 | $49,906 |
| Total Liabilities And Equity | $36,862 | $40,389 | $44,834 | $51,844 | $53,948 |